nodes	percent_of_prediction	percent_of_DWPC	metapath
Salicylate-sodium—PTGS2—ovarian follicle—ovarian cancer	0.0469	0.304	CbGeAlD
Salicylate-sodium—PTGS1—oviduct—ovarian cancer	0.0215	0.14	CbGeAlD
Salicylate-sodium—Acetylsalicylic acid—TP53—ovarian cancer	0.0103	0.767	CrCbGaD
Salicylate-sodium—PTGS2—myometrium—ovarian cancer	0.00659	0.0427	CbGeAlD
Salicylate-sodium—PTGS2—embryo—ovarian cancer	0.00634	0.0411	CbGeAlD
Salicylate-sodium—PTGS1—epithelium—ovarian cancer	0.00541	0.0351	CbGeAlD
Salicylate-sodium—PTGS1—uterine cervix—ovarian cancer	0.00537	0.0348	CbGeAlD
Salicylate-sodium—PTGS2—epithelium—ovarian cancer	0.00517	0.0335	CbGeAlD
Salicylate-sodium—PTGS2—uterine cervix—ovarian cancer	0.00513	0.0332	CbGeAlD
Salicylate-sodium—PTGS1—endometrium—ovarian cancer	0.00485	0.0315	CbGeAlD
Salicylate-sodium—PTGS2—endometrium—ovarian cancer	0.00464	0.0301	CbGeAlD
Salicylate-sodium—PTGS1—uterus—ovarian cancer	0.00447	0.029	CbGeAlD
Salicylate-sodium—PTGS2—uterus—ovarian cancer	0.00427	0.0277	CbGeAlD
Salicylate-sodium—PTGS1—female reproductive system—ovarian cancer	0.00402	0.0261	CbGeAlD
Salicylate-sodium—PTGS2—female reproductive system—ovarian cancer	0.00384	0.0249	CbGeAlD
Salicylate-sodium—PTGS1—female gonad—ovarian cancer	0.00366	0.0237	CbGeAlD
Salicylate-sodium—PTGS1—vagina—ovarian cancer	0.00364	0.0236	CbGeAlD
Salicylate-sodium—PTGS2—bone marrow—ovarian cancer	0.00363	0.0235	CbGeAlD
Salicylate-sodium—PTGS2—female gonad—ovarian cancer	0.0035	0.0227	CbGeAlD
Salicylate-sodium—PTGS2—vagina—ovarian cancer	0.00348	0.0225	CbGeAlD
Salicylate-sodium—PTGS1—testis—ovarian cancer	0.00324	0.021	CbGeAlD
Salicylate-sodium—PTGS1—lymph node—ovarian cancer	0.00235	0.0152	CbGeAlD
Salicylate-sodium—PTGS2—lymph node—ovarian cancer	0.00225	0.0146	CbGeAlD
Salicylate-sodium—Acetylsalicylic acid—ABCB1—ovarian cancer	0.00172	0.128	CrCbGaD
Salicylate-sodium—Salicylic acid—ABCB1—ovarian cancer	0.00142	0.105	CrCbGaD
Salicylate-sodium—Hypersensitivity—Topotecan—ovarian cancer	0.00128	0.00154	CcSEcCtD
Salicylate-sodium—Constipation—Vinorelbine—ovarian cancer	0.00127	0.00152	CcSEcCtD
Salicylate-sodium—Pain—Vinorelbine—ovarian cancer	0.00127	0.00152	CcSEcCtD
Salicylate-sodium—Renal failure acute—Epirubicin—ovarian cancer	0.00126	0.00151	CcSEcCtD
Salicylate-sodium—Arrhythmia—Paclitaxel—ovarian cancer	0.00125	0.00151	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Melphalan—ovarian cancer	0.00125	0.0015	CcSEcCtD
Salicylate-sodium—Epistaxis—Docetaxel—ovarian cancer	0.00125	0.0015	CcSEcCtD
Salicylate-sodium—Phlebitis—Doxorubicin—ovarian cancer	0.00125	0.0015	CcSEcCtD
Salicylate-sodium—Asthenia—Topotecan—ovarian cancer	0.00124	0.0015	CcSEcCtD
Salicylate-sodium—Vomiting—Chlorambucil—ovarian cancer	0.00124	0.00149	CcSEcCtD
Salicylate-sodium—Pruritus—Topotecan—ovarian cancer	0.00123	0.00147	CcSEcCtD
Salicylate-sodium—Erythema—Paclitaxel—ovarian cancer	0.00122	0.00147	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Vinorelbine—ovarian cancer	0.00122	0.00147	CcSEcCtD
Salicylate-sodium—Renal impairment—Epirubicin—ovarian cancer	0.00122	0.00147	CcSEcCtD
Salicylate-sodium—Asthenia—Melphalan—ovarian cancer	0.00122	0.00146	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.00121	0.00146	CcSEcCtD
Salicylate-sodium—Flatulence—Paclitaxel—ovarian cancer	0.0012	0.00145	CcSEcCtD
Salicylate-sodium—Pruritus—Melphalan—ovarian cancer	0.0012	0.00144	CcSEcCtD
Salicylate-sodium—Dysgeusia—Paclitaxel—ovarian cancer	0.0012	0.00144	CcSEcCtD
Salicylate-sodium—Hepatitis—Docetaxel—ovarian cancer	0.00119	0.00143	CcSEcCtD
Salicylate-sodium—Diarrhoea—Topotecan—ovarian cancer	0.00119	0.00143	CcSEcCtD
Salicylate-sodium—Hypoaesthesia—Docetaxel—ovarian cancer	0.00118	0.00142	CcSEcCtD
Salicylate-sodium—Lethargy—Epirubicin—ovarian cancer	0.00118	0.00142	CcSEcCtD
Salicylate-sodium—Cerebrovascular accident—Epirubicin—ovarian cancer	0.00118	0.00142	CcSEcCtD
Salicylate-sodium—Cardiac failure congestive—Doxorubicin—ovarian cancer	0.00118	0.00142	CcSEcCtD
Salicylate-sodium—Urticaria—Vinorelbine—ovarian cancer	0.00118	0.00142	CcSEcCtD
Salicylate-sodium—Body temperature increased—Vinorelbine—ovarian cancer	0.00117	0.00141	CcSEcCtD
Salicylate-sodium—Abdominal pain—Vinorelbine—ovarian cancer	0.00117	0.00141	CcSEcCtD
Salicylate-sodium—Renal failure acute—Doxorubicin—ovarian cancer	0.00116	0.0014	CcSEcCtD
Salicylate-sodium—Diarrhoea—Melphalan—ovarian cancer	0.00116	0.0014	CcSEcCtD
Salicylate-sodium—Nausea—Chlorambucil—ovarian cancer	0.00116	0.00139	CcSEcCtD
Salicylate-sodium—Vision blurred—Paclitaxel—ovarian cancer	0.00115	0.00138	CcSEcCtD
Salicylate-sodium—Dizziness—Topotecan—ovarian cancer	0.00115	0.00138	CcSEcCtD
Salicylate-sodium—Renal impairment—Doxorubicin—ovarian cancer	0.00113	0.00136	CcSEcCtD
Salicylate-sodium—Erythema multiforme—Docetaxel—ovarian cancer	0.00113	0.00135	CcSEcCtD
Salicylate-sodium—Vomiting—Topotecan—ovarian cancer	0.0011	0.00133	CcSEcCtD
Salicylate-sodium—Syncope—Paclitaxel—ovarian cancer	0.0011	0.00132	CcSEcCtD
Salicylate-sodium—Lethargy—Doxorubicin—ovarian cancer	0.0011	0.00132	CcSEcCtD
Salicylate-sodium—Cerebrovascular accident—Doxorubicin—ovarian cancer	0.0011	0.00132	CcSEcCtD
Salicylate-sodium—Rash—Topotecan—ovarian cancer	0.00109	0.00131	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Vinorelbine—ovarian cancer	0.00109	0.00131	CcSEcCtD
Salicylate-sodium—Dermatitis—Topotecan—ovarian cancer	0.00109	0.00131	CcSEcCtD
Salicylate-sodium—Blood creatinine increased—Epirubicin—ovarian cancer	0.00109	0.00131	CcSEcCtD
Salicylate-sodium—Headache—Topotecan—ovarian cancer	0.00109	0.00131	CcSEcCtD
Salicylate-sodium—Palpitations—Paclitaxel—ovarian cancer	0.00108	0.0013	CcSEcCtD
Salicylate-sodium—Vomiting—Melphalan—ovarian cancer	0.00108	0.0013	CcSEcCtD
Salicylate-sodium—Dehydration—Epirubicin—ovarian cancer	0.00108	0.0013	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Paclitaxel—ovarian cancer	0.00107	0.00129	CcSEcCtD
Salicylate-sodium—Rash—Melphalan—ovarian cancer	0.00107	0.00129	CcSEcCtD
Salicylate-sodium—Dermatitis—Melphalan—ovarian cancer	0.00107	0.00129	CcSEcCtD
Salicylate-sodium—Asthenia—Vinorelbine—ovarian cancer	0.00106	0.00128	CcSEcCtD
Salicylate-sodium—Arrhythmia—Docetaxel—ovarian cancer	0.00106	0.00128	CcSEcCtD
Salicylate-sodium—Abdominal pain upper—Epirubicin—ovarian cancer	0.00106	0.00127	CcSEcCtD
Salicylate-sodium—Convulsion—Paclitaxel—ovarian cancer	0.00106	0.00127	CcSEcCtD
Salicylate-sodium—Hypokalaemia—Epirubicin—ovarian cancer	0.00106	0.00127	CcSEcCtD
Salicylate-sodium—Pruritus—Vinorelbine—ovarian cancer	0.00105	0.00126	CcSEcCtD
Salicylate-sodium—Chest pain—Paclitaxel—ovarian cancer	0.00104	0.00125	CcSEcCtD
Salicylate-sodium—Anxiety—Paclitaxel—ovarian cancer	0.00104	0.00125	CcSEcCtD
Salicylate-sodium—Erythema—Docetaxel—ovarian cancer	0.00104	0.00125	CcSEcCtD
Salicylate-sodium—Nausea—Topotecan—ovarian cancer	0.00103	0.00124	CcSEcCtD
Salicylate-sodium—Diarrhoea—Vinorelbine—ovarian cancer	0.00102	0.00122	CcSEcCtD
Salicylate-sodium—Dysgeusia—Docetaxel—ovarian cancer	0.00101	0.00122	CcSEcCtD
Salicylate-sodium—Abdominal distension—Epirubicin—ovarian cancer	0.00101	0.00121	CcSEcCtD
Salicylate-sodium—Nausea—Melphalan—ovarian cancer	0.00101	0.00121	CcSEcCtD
Salicylate-sodium—Confusional state—Paclitaxel—ovarian cancer	0.00101	0.00121	CcSEcCtD
Salicylate-sodium—Blood creatinine increased—Doxorubicin—ovarian cancer	0.00101	0.00121	CcSEcCtD
Salicylate-sodium—Asthma—Epirubicin—ovarian cancer	0.001	0.00121	CcSEcCtD
Salicylate-sodium—Dysphagia—Epirubicin—ovarian cancer	0.001	0.00121	CcSEcCtD
Salicylate-sodium—Dehydration—Doxorubicin—ovarian cancer	0.000999	0.0012	CcSEcCtD
Salicylate-sodium—Oedema—Paclitaxel—ovarian cancer	0.000998	0.0012	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000998	0.0012	CcSEcCtD
Salicylate-sodium—Infection—Paclitaxel—ovarian cancer	0.000991	0.00119	CcSEcCtD
Salicylate-sodium—Shock—Paclitaxel—ovarian cancer	0.000982	0.00118	CcSEcCtD
Salicylate-sodium—Dizziness—Vinorelbine—ovarian cancer	0.000981	0.00118	CcSEcCtD
Salicylate-sodium—Abdominal pain upper—Doxorubicin—ovarian cancer	0.000981	0.00118	CcSEcCtD
Salicylate-sodium—Hypokalaemia—Doxorubicin—ovarian cancer	0.000978	0.00117	CcSEcCtD
Salicylate-sodium—Tachycardia—Paclitaxel—ovarian cancer	0.000974	0.00117	CcSEcCtD
Salicylate-sodium—Bronchitis—Epirubicin—ovarian cancer	0.000965	0.00116	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000965	0.00116	CcSEcCtD
Salicylate-sodium—Anorexia—Paclitaxel—ovarian cancer	0.000951	0.00114	CcSEcCtD
Salicylate-sodium—Vomiting—Vinorelbine—ovarian cancer	0.000943	0.00113	CcSEcCtD
Salicylate-sodium—Rash—Vinorelbine—ovarian cancer	0.000935	0.00112	CcSEcCtD
Salicylate-sodium—Dermatitis—Vinorelbine—ovarian cancer	0.000935	0.00112	CcSEcCtD
Salicylate-sodium—Abdominal distension—Doxorubicin—ovarian cancer	0.000935	0.00112	CcSEcCtD
Salicylate-sodium—Hypotension—Paclitaxel—ovarian cancer	0.000933	0.00112	CcSEcCtD
Salicylate-sodium—Headache—Vinorelbine—ovarian cancer	0.000929	0.00112	CcSEcCtD
Salicylate-sodium—Syncope—Docetaxel—ovarian cancer	0.000929	0.00112	CcSEcCtD
Salicylate-sodium—Dysphagia—Doxorubicin—ovarian cancer	0.000928	0.00112	CcSEcCtD
Salicylate-sodium—Asthma—Doxorubicin—ovarian cancer	0.000928	0.00112	CcSEcCtD
Salicylate-sodium—Palpitations—Docetaxel—ovarian cancer	0.000916	0.0011	CcSEcCtD
Salicylate-sodium—Weight increased—Epirubicin—ovarian cancer	0.000913	0.0011	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Docetaxel—ovarian cancer	0.000911	0.00109	CcSEcCtD
Salicylate-sodium—Convulsion—Docetaxel—ovarian cancer	0.000898	0.00108	CcSEcCtD
Salicylate-sodium—Paraesthesia—Paclitaxel—ovarian cancer	0.000896	0.00108	CcSEcCtD
Salicylate-sodium—Drowsiness—Epirubicin—ovarian cancer	0.000895	0.00107	CcSEcCtD
Salicylate-sodium—Bronchitis—Doxorubicin—ovarian cancer	0.000893	0.00107	CcSEcCtD
Salicylate-sodium—Dyspnoea—Paclitaxel—ovarian cancer	0.00089	0.00107	CcSEcCtD
Salicylate-sodium—Somnolence—Paclitaxel—ovarian cancer	0.000887	0.00107	CcSEcCtD
Salicylate-sodium—Chest pain—Docetaxel—ovarian cancer	0.000882	0.00106	CcSEcCtD
Salicylate-sodium—Nausea—Vinorelbine—ovarian cancer	0.000881	0.00106	CcSEcCtD
Salicylate-sodium—Renal failure—Epirubicin—ovarian cancer	0.000879	0.00106	CcSEcCtD
Salicylate-sodium—Dyspepsia—Paclitaxel—ovarian cancer	0.000878	0.00106	CcSEcCtD
Salicylate-sodium—Decreased appetite—Paclitaxel—ovarian cancer	0.000868	0.00104	CcSEcCtD
Salicylate-sodium—Fatigue—Paclitaxel—ovarian cancer	0.00086	0.00103	CcSEcCtD
Salicylate-sodium—Constipation—Paclitaxel—ovarian cancer	0.000853	0.00103	CcSEcCtD
Salicylate-sodium—Pain—Paclitaxel—ovarian cancer	0.000853	0.00103	CcSEcCtD
Salicylate-sodium—Confusional state—Docetaxel—ovarian cancer	0.000853	0.00102	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Docetaxel—ovarian cancer	0.000846	0.00102	CcSEcCtD
Salicylate-sodium—Oedema—Docetaxel—ovarian cancer	0.000846	0.00102	CcSEcCtD
Salicylate-sodium—Weight increased—Doxorubicin—ovarian cancer	0.000845	0.00102	CcSEcCtD
Salicylate-sodium—Epistaxis—Epirubicin—ovarian cancer	0.000844	0.00101	CcSEcCtD
Salicylate-sodium—Infection—Docetaxel—ovarian cancer	0.00084	0.00101	CcSEcCtD
Salicylate-sodium—Shock—Docetaxel—ovarian cancer	0.000832	0.001	CcSEcCtD
Salicylate-sodium—Drowsiness—Doxorubicin—ovarian cancer	0.000828	0.000995	CcSEcCtD
Salicylate-sodium—Tachycardia—Docetaxel—ovarian cancer	0.000826	0.000992	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Paclitaxel—ovarian cancer	0.000822	0.000988	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000816	0.000981	CcSEcCtD
Salicylate-sodium—Renal failure—Doxorubicin—ovarian cancer	0.000814	0.000978	CcSEcCtD
Salicylate-sodium—Anorexia—Docetaxel—ovarian cancer	0.000806	0.000969	CcSEcCtD
Salicylate-sodium—Hepatitis—Epirubicin—ovarian cancer	0.000803	0.000965	CcSEcCtD
Salicylate-sodium—Hypoaesthesia—Epirubicin—ovarian cancer	0.000799	0.00096	CcSEcCtD
Salicylate-sodium—Urticaria—Paclitaxel—ovarian cancer	0.000793	0.000953	CcSEcCtD
Salicylate-sodium—Hypotension—Docetaxel—ovarian cancer	0.00079	0.00095	CcSEcCtD
Salicylate-sodium—Abdominal pain—Paclitaxel—ovarian cancer	0.000789	0.000948	CcSEcCtD
Salicylate-sodium—Body temperature increased—Paclitaxel—ovarian cancer	0.000789	0.000948	CcSEcCtD
Salicylate-sodium—Epistaxis—Doxorubicin—ovarian cancer	0.000781	0.000938	CcSEcCtD
Salicylate-sodium—Paraesthesia—Docetaxel—ovarian cancer	0.00076	0.000913	CcSEcCtD
Salicylate-sodium—Erythema multiforme—Epirubicin—ovarian cancer	0.000759	0.000912	CcSEcCtD
Salicylate-sodium—Dyspnoea—Docetaxel—ovarian cancer	0.000754	0.000906	CcSEcCtD
Salicylate-sodium—Somnolence—Docetaxel—ovarian cancer	0.000752	0.000904	CcSEcCtD
Salicylate-sodium—Tinnitus—Epirubicin—ovarian cancer	0.000749	0.0009	CcSEcCtD
Salicylate-sodium—Dyspepsia—Docetaxel—ovarian cancer	0.000745	0.000895	CcSEcCtD
Salicylate-sodium—Hepatitis—Doxorubicin—ovarian cancer	0.000743	0.000893	CcSEcCtD
Salicylate-sodium—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000739	0.000888	CcSEcCtD
Salicylate-sodium—Decreased appetite—Docetaxel—ovarian cancer	0.000735	0.000884	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Paclitaxel—ovarian cancer	0.000735	0.000883	CcSEcCtD
Salicylate-sodium—Fatigue—Docetaxel—ovarian cancer	0.000729	0.000876	CcSEcCtD
Salicylate-sodium—Pain—Docetaxel—ovarian cancer	0.000723	0.000869	CcSEcCtD
Salicylate-sodium—Constipation—Docetaxel—ovarian cancer	0.000723	0.000869	CcSEcCtD
Salicylate-sodium—Arrhythmia—Epirubicin—ovarian cancer	0.000717	0.000862	CcSEcCtD
Salicylate-sodium—Asthenia—Paclitaxel—ovarian cancer	0.000716	0.00086	CcSEcCtD
Salicylate-sodium—Pruritus—Paclitaxel—ovarian cancer	0.000706	0.000848	CcSEcCtD
Salicylate-sodium—Erythema multiforme—Doxorubicin—ovarian cancer	0.000703	0.000844	CcSEcCtD
Salicylate-sodium—Erythema—Epirubicin—ovarian cancer	0.000699	0.00084	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Docetaxel—ovarian cancer	0.000697	0.000838	CcSEcCtD
Salicylate-sodium—Tinnitus—Doxorubicin—ovarian cancer	0.000693	0.000832	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000692	0.000831	CcSEcCtD
Salicylate-sodium—Flatulence—Epirubicin—ovarian cancer	0.000689	0.000828	CcSEcCtD
Salicylate-sodium—Dysgeusia—Epirubicin—ovarian cancer	0.000685	0.000823	CcSEcCtD
Salicylate-sodium—Diarrhoea—Paclitaxel—ovarian cancer	0.000683	0.00082	CcSEcCtD
Salicylate-sodium—Abdominal pain—Docetaxel—ovarian cancer	0.000669	0.000803	CcSEcCtD
Salicylate-sodium—Body temperature increased—Docetaxel—ovarian cancer	0.000669	0.000803	CcSEcCtD
Salicylate-sodium—Arrhythmia—Doxorubicin—ovarian cancer	0.000664	0.000798	CcSEcCtD
Salicylate-sodium—Dizziness—Paclitaxel—ovarian cancer	0.00066	0.000793	CcSEcCtD
Salicylate-sodium—Vision blurred—Epirubicin—ovarian cancer	0.000659	0.000792	CcSEcCtD
Salicylate-sodium—Erythema—Doxorubicin—ovarian cancer	0.000647	0.000777	CcSEcCtD
Salicylate-sodium—Flatulence—Doxorubicin—ovarian cancer	0.000637	0.000766	CcSEcCtD
Salicylate-sodium—Vomiting—Paclitaxel—ovarian cancer	0.000635	0.000762	CcSEcCtD
Salicylate-sodium—Dysgeusia—Doxorubicin—ovarian cancer	0.000633	0.000761	CcSEcCtD
Salicylate-sodium—Rash—Paclitaxel—ovarian cancer	0.000629	0.000756	CcSEcCtD
Salicylate-sodium—Dermatitis—Paclitaxel—ovarian cancer	0.000629	0.000755	CcSEcCtD
Salicylate-sodium—Syncope—Epirubicin—ovarian cancer	0.000627	0.000753	CcSEcCtD
Salicylate-sodium—Headache—Paclitaxel—ovarian cancer	0.000625	0.000751	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Docetaxel—ovarian cancer	0.000623	0.000749	CcSEcCtD
Salicylate-sodium—Palpitations—Epirubicin—ovarian cancer	0.000618	0.000742	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Epirubicin—ovarian cancer	0.000614	0.000738	CcSEcCtD
Salicylate-sodium—Vision blurred—Doxorubicin—ovarian cancer	0.00061	0.000732	CcSEcCtD
Salicylate-sodium—Asthenia—Docetaxel—ovarian cancer	0.000607	0.000729	CcSEcCtD
Salicylate-sodium—Convulsion—Epirubicin—ovarian cancer	0.000606	0.000728	CcSEcCtD
Salicylate-sodium—Pruritus—Docetaxel—ovarian cancer	0.000598	0.000719	CcSEcCtD
Salicylate-sodium—Chest pain—Epirubicin—ovarian cancer	0.000595	0.000715	CcSEcCtD
Salicylate-sodium—Anxiety—Epirubicin—ovarian cancer	0.000593	0.000713	CcSEcCtD
Salicylate-sodium—Nausea—Paclitaxel—ovarian cancer	0.000593	0.000712	CcSEcCtD
Salicylate-sodium—Syncope—Doxorubicin—ovarian cancer	0.00058	0.000697	CcSEcCtD
Salicylate-sodium—Diarrhoea—Docetaxel—ovarian cancer	0.000579	0.000695	CcSEcCtD
Salicylate-sodium—Confusional state—Epirubicin—ovarian cancer	0.000575	0.000691	CcSEcCtD
Salicylate-sodium—Palpitations—Doxorubicin—ovarian cancer	0.000572	0.000687	CcSEcCtD
Salicylate-sodium—Oedema—Epirubicin—ovarian cancer	0.000571	0.000686	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Epirubicin—ovarian cancer	0.000571	0.000686	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Doxorubicin—ovarian cancer	0.000569	0.000683	CcSEcCtD
Salicylate-sodium—Infection—Epirubicin—ovarian cancer	0.000567	0.000681	CcSEcCtD
Salicylate-sodium—Shock—Epirubicin—ovarian cancer	0.000561	0.000674	CcSEcCtD
Salicylate-sodium—Convulsion—Doxorubicin—ovarian cancer	0.00056	0.000673	CcSEcCtD
Salicylate-sodium—Dizziness—Docetaxel—ovarian cancer	0.000559	0.000672	CcSEcCtD
Salicylate-sodium—Tachycardia—Epirubicin—ovarian cancer	0.000557	0.000669	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Epirubicin—ovarian cancer	0.000552	0.000663	CcSEcCtD
Salicylate-sodium—Chest pain—Doxorubicin—ovarian cancer	0.000551	0.000662	CcSEcCtD
Salicylate-sodium—Anxiety—Doxorubicin—ovarian cancer	0.000549	0.000659	CcSEcCtD
Salicylate-sodium—Anorexia—Epirubicin—ovarian cancer	0.000544	0.000653	CcSEcCtD
Salicylate-sodium—Vomiting—Docetaxel—ovarian cancer	0.000538	0.000646	CcSEcCtD
Salicylate-sodium—Rash—Docetaxel—ovarian cancer	0.000533	0.000641	CcSEcCtD
Salicylate-sodium—Hypotension—Epirubicin—ovarian cancer	0.000533	0.000641	CcSEcCtD
Salicylate-sodium—Dermatitis—Docetaxel—ovarian cancer	0.000533	0.00064	CcSEcCtD
Salicylate-sodium—Confusional state—Doxorubicin—ovarian cancer	0.000532	0.00064	CcSEcCtD
Salicylate-sodium—Headache—Docetaxel—ovarian cancer	0.00053	0.000637	CcSEcCtD
Salicylate-sodium—Oedema—Doxorubicin—ovarian cancer	0.000528	0.000634	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000528	0.000634	CcSEcCtD
Salicylate-sodium—Infection—Doxorubicin—ovarian cancer	0.000524	0.00063	CcSEcCtD
Salicylate-sodium—Shock—Doxorubicin—ovarian cancer	0.000519	0.000624	CcSEcCtD
Salicylate-sodium—Tachycardia—Doxorubicin—ovarian cancer	0.000515	0.000619	CcSEcCtD
Salicylate-sodium—Paraesthesia—Epirubicin—ovarian cancer	0.000512	0.000616	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Doxorubicin—ovarian cancer	0.00051	0.000613	CcSEcCtD
Salicylate-sodium—Dyspnoea—Epirubicin—ovarian cancer	0.000509	0.000611	CcSEcCtD
Salicylate-sodium—Somnolence—Epirubicin—ovarian cancer	0.000507	0.000609	CcSEcCtD
Salicylate-sodium—Anorexia—Doxorubicin—ovarian cancer	0.000503	0.000605	CcSEcCtD
Salicylate-sodium—Nausea—Docetaxel—ovarian cancer	0.000502	0.000604	CcSEcCtD
Salicylate-sodium—Dyspepsia—Epirubicin—ovarian cancer	0.000502	0.000603	CcSEcCtD
Salicylate-sodium—Decreased appetite—Epirubicin—ovarian cancer	0.000496	0.000596	CcSEcCtD
Salicylate-sodium—Hypotension—Doxorubicin—ovarian cancer	0.000493	0.000593	CcSEcCtD
Salicylate-sodium—Fatigue—Epirubicin—ovarian cancer	0.000492	0.000591	CcSEcCtD
Salicylate-sodium—Constipation—Epirubicin—ovarian cancer	0.000488	0.000586	CcSEcCtD
Salicylate-sodium—Pain—Epirubicin—ovarian cancer	0.000488	0.000586	CcSEcCtD
Salicylate-sodium—Paraesthesia—Doxorubicin—ovarian cancer	0.000474	0.00057	CcSEcCtD
Salicylate-sodium—Dyspnoea—Doxorubicin—ovarian cancer	0.000471	0.000566	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Epirubicin—ovarian cancer	0.00047	0.000565	CcSEcCtD
Salicylate-sodium—Somnolence—Doxorubicin—ovarian cancer	0.000469	0.000564	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000467	0.000561	CcSEcCtD
Salicylate-sodium—Dyspepsia—Doxorubicin—ovarian cancer	0.000465	0.000558	CcSEcCtD
Salicylate-sodium—Decreased appetite—Doxorubicin—ovarian cancer	0.000459	0.000551	CcSEcCtD
Salicylate-sodium—Fatigue—Doxorubicin—ovarian cancer	0.000455	0.000547	CcSEcCtD
Salicylate-sodium—Urticaria—Epirubicin—ovarian cancer	0.000453	0.000545	CcSEcCtD
Salicylate-sodium—Constipation—Doxorubicin—ovarian cancer	0.000451	0.000542	CcSEcCtD
Salicylate-sodium—Pain—Doxorubicin—ovarian cancer	0.000451	0.000542	CcSEcCtD
Salicylate-sodium—Abdominal pain—Epirubicin—ovarian cancer	0.000451	0.000542	CcSEcCtD
Salicylate-sodium—Body temperature increased—Epirubicin—ovarian cancer	0.000451	0.000542	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Doxorubicin—ovarian cancer	0.000435	0.000523	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000432	0.000519	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Epirubicin—ovarian cancer	0.00042	0.000505	CcSEcCtD
Salicylate-sodium—Urticaria—Doxorubicin—ovarian cancer	0.000419	0.000504	CcSEcCtD
Salicylate-sodium—Body temperature increased—Doxorubicin—ovarian cancer	0.000417	0.000501	CcSEcCtD
Salicylate-sodium—Abdominal pain—Doxorubicin—ovarian cancer	0.000417	0.000501	CcSEcCtD
Salicylate-sodium—Asthenia—Epirubicin—ovarian cancer	0.000409	0.000492	CcSEcCtD
Salicylate-sodium—Pruritus—Epirubicin—ovarian cancer	0.000404	0.000485	CcSEcCtD
Salicylate-sodium—Diarrhoea—Epirubicin—ovarian cancer	0.00039	0.000469	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Doxorubicin—ovarian cancer	0.000389	0.000467	CcSEcCtD
Salicylate-sodium—Asthenia—Doxorubicin—ovarian cancer	0.000379	0.000455	CcSEcCtD
Salicylate-sodium—Dizziness—Epirubicin—ovarian cancer	0.000377	0.000453	CcSEcCtD
Salicylate-sodium—Pruritus—Doxorubicin—ovarian cancer	0.000373	0.000449	CcSEcCtD
Salicylate-sodium—Vomiting—Epirubicin—ovarian cancer	0.000363	0.000436	CcSEcCtD
Salicylate-sodium—Diarrhoea—Doxorubicin—ovarian cancer	0.000361	0.000434	CcSEcCtD
Salicylate-sodium—Rash—Epirubicin—ovarian cancer	0.00036	0.000432	CcSEcCtD
Salicylate-sodium—Dermatitis—Epirubicin—ovarian cancer	0.000359	0.000432	CcSEcCtD
Salicylate-sodium—Headache—Epirubicin—ovarian cancer	0.000357	0.000429	CcSEcCtD
Salicylate-sodium—Dizziness—Doxorubicin—ovarian cancer	0.000349	0.000419	CcSEcCtD
Salicylate-sodium—Nausea—Epirubicin—ovarian cancer	0.000339	0.000407	CcSEcCtD
Salicylate-sodium—Vomiting—Doxorubicin—ovarian cancer	0.000336	0.000403	CcSEcCtD
Salicylate-sodium—Rash—Doxorubicin—ovarian cancer	0.000333	0.0004	CcSEcCtD
Salicylate-sodium—Dermatitis—Doxorubicin—ovarian cancer	0.000333	0.0004	CcSEcCtD
Salicylate-sodium—Headache—Doxorubicin—ovarian cancer	0.000331	0.000397	CcSEcCtD
Salicylate-sodium—Nausea—Doxorubicin—ovarian cancer	0.000314	0.000377	CcSEcCtD
